10x Genomics Affirms FY2026 Sales Guidance of $600.000M-$625.000M vs $613.107M Est.

Benzinga Newsdesk www.benzinga.com Negative 62.2%

Neg 62.2% Neu 0% Pos 0%

10x Genomics (NASDAQ:TXG) affirms FY2026 sales outlook from $600.000 million-$625.000 million to $600.000 million-$625.000 million vs $613.107 million estimate.